中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Issue 4
Apr.  2017

The most appropriate timing for selective laparoscopic cholecystectomy after percutaneous transhepatic gallbladder drainage in patients with acute severe cholecystitis aged above 60 years

DOI: 10.3969/j.issn.1001-5256.2017.04.021
  • Received Date: 2016-10-12
  • Published Date: 2017-04-20
  • Objective To investigate the clinical effect of selective laparoscopic cholecystectomy (LC) after percutaneous transhepatic gallbladder drainage (PTGD) in the treatment of elderly patients with acute severe cholecystitis, as well as the most appropriate timing for selective operation.Methods A total of 90 patients with acute severe cholecystitis aged above 60 years who were admitted to Department of Hepatobiliary Surgery in The First Hospital of Jilin University from January 2015 to June 2016 were enrolled, and according to the time of selective LC, they were divided into group A (with 2 months) , group B (2-4 months) , and group C (>4 months) , with 30 patients in each group.The clinical effects of PTGD and selective LC were observed.The t-test was used for comparison of continuous data between two groups, an analysis of variance was used for comparison between three groups, and LSD-t test was used for comparison between any two groups; the chi-square test was used for comparison of categorical data between groups.Results All the patients underwent successful PTGD, and the time to abdominal pain remission was 2.52 ± 0.76 hours.Body temperature returned to normal with 24-72 hours after surgery, and there were significant improvements in laboratory markers (white blood cell count, neutrophil count, and liver function) (all P<0.05) .No patient experienced complications such as bile leakage, hematobilia, pneumothorax, and colon perforation caused by puncture, and there was no case of PTGD after the tube was detached.There were significant differences between the three groups in gallbladder wall thickness before LC (F=8.029, P<0.001) , time of operation (F=24.674, P<0.001) , intraoperative blood loss (F=12.864, P<0.001) , length of hospital stay (F=22.844, P<0.001) , rate of conversion to laparotomy (χ2=12.345, P=0.002) , and incidence rate of complications (χ2=8.750, P=0.013) .Compared with group A, groups B and C had significantly lower gallbladder wall thickness before LC, intraoperative blood loss, length of hospital stay, rate of conversion to laparotomy, and incidence rate of complications (all P<0.05) , and group B had significantly lower time of operation, intraoperative blood loss, and length of hospital stay than group C (all P<0.05) .Conclusion Selective LC with 2-4 months after PTGD has a marked clinical effect and high safety in the treatment of elderly patients with acute severe cholecystitis.

     

  • [1]XIA MF, ZHANG S, TIAN H, et al.Study of the effects of percutaneous transhepatic gallbladder drainage guided by B ultrasound in the treatment of elderly patients with critical calculus obstructive cholecystitis[J].China J Modern Med, 2014, 24 (21) :102-105. (in Chinese) 夏明峰, 张帅, 田虎, 等.B超引导下经皮肝胆囊穿刺治疗老年危重结石梗阻性胆囊炎[J].中国现代医学杂志, 2014, 24 (21) :102-105.
    [2]HUA SY, XU RL, QI B, et al.Clinical value of percutaneous gallbladder catheterized drainage in the treatment of acute severe cholecystitis[J].J Southeast Univ:Med Sci Edit, 2014, 33 (4) :479-481. (in Chinese) 华双一, 徐仁良, 祁波, 等.经皮胆囊穿刺置管引流治疗高危急性胆囊炎[J].东南大学学报:医学版, 2014, 33 (4) :479-481.
    [3]PEPINGCO L, ESLICK GD, COX MR.The acute surgical unit as a novel model of care for patients presenting with acute cholecystitis[J].Med J Aust, 2012, 196 (8) :509-510.
    [4]FEI HJ, SU ZJ, PAN QX, et al.Clinical effet of percutaneous transhepatic gallbladder drainage combined with selective laparoscopic cholecystectomy in treatment of acute severe cholecysitis:an analysis of 386 cases[J].J Hepatopancreatobiliary Surg, 2014, 26 (6) :486-488. (in Chinese) 费洪江, 苏子剑, 潘群雄, 等.经皮经肝胆囊穿刺引流术加择期腹腔镜胆囊切除术治疗急性重症胆囊炎386例分析[J].肝胆胰外科杂志, 2014, 26 (6) :486-488.
    [5]ABI-HAIDAR Y, SANCHEZ V, WILLIAMS SA, et al.Revisiting percutaneous cholecystostomy for acute cholecystitis based on a10-year experience[J].Arch Surg, 2012, 147 (5) :416-422.
    [6]JIANG B.The research of opportunity selection in acute calculous cholecystitis laparoscopic cholecystectomy[D].Dalian:Dalian Med Univ, 2014. (in Chinese) 江滨.急性结石性胆囊炎腹腔镜手术时机的选择[D].大连医科大学, 2014.
    [7] Biliary Surgery Group, Surgery Branch of Chinese Medical Association.Diagnosis and treatment guidelines for acute biliary infection (2011 edition) [J].Chin J Dig Surg, 2011, 10 (1) :9-13. (in Chinese) 中华医学会外科学分会胆道外科学组.急性胆道系统感染的诊断和治疗指南 (2011版) [J].中华消化外科杂志, 2011, 10 (1) :9-13.
    [8]YAMASHITA Y, TAKADA T, KAWARADA Y, et al.Surgical treatment of patients with acute cholecystitis:Tokyo guidelines[J].J Hepatobiliary Pancreat Surg, 2007, 14 (1) :91-97.
    [9]XU D.Study on indications for extubation of percutaneous transhepatic gallbladder drainage[D].Shihezi:Shihezi Univ, 2014. (in Chinese) 徐东.经皮经肝胆囊穿刺引流术后拔管指征的探讨[D].石河子大学, 2014.
    [10]JIANG JT, LI Q.Clinical effect of sequential percutaneous transhepatic gallbladder drainage and laparoscopic cholecystectomy in treatment of acute severe cholecystitis in elderly patients[J].Zhejiang Pract Med, 2015, 20 (3) :206-207. (in Chinese) 蒋建庭, 李巧.经皮经肝胆囊穿刺引流术序贯腹腔镜胆囊切除术治疗老年急性重症胆囊炎[J].浙江实用医学, 2015, 20 (3) :206-207.
    [11]ZHANG JJ, LI HZ.Clinical analysis of Lidan Paishi Tang in expectant treatment of chronic cholecystitis[J].Chin J Exp Med Formul, 2016, 22 (7) :187-190. (in Chinese) 张洁靖, 李汉智.利胆排石汤保守治疗慢性胆囊炎的临床分析[J].中国实验方剂学杂志, 2016, 22 (7) :187-190.
    [12]XIE MP, WANG J.Current research status of acute cholecystitis in elderly patients[J].Trauma Crit Med, 2016, 4 (1) :62-64. (in Chinese) 解民鹏, 王静.高龄患者急性胆囊炎研究现状[J].创伤与急危重病医学, 2016, 4 (1) :62-64.
    [13]LENG K, LUO YQ, ZENG PF.Percutaneous transhepatic gallbladder catheterizing drainage guided by ultrasound for acute severe cholecystitis in the senile patients[J].China J Modern Med, 2014, 24 (24) :86-88. (in Chinese) 冷凯, 罗燕青, 曾鹏飞.老年急性胆囊炎经皮经肝胆囊穿刺引流术应用[J].中国现代医学杂志, 2014, 24 (24) :86-88.
    [14]HUANG ZM, XU L, ZHOU D.Laparoscopic cholecystectomy for acute cholecystitis[J].Chin J Gen Surg, 2012, 21 (8) :1038-1040. (in Chinese) 黄志明, 徐亮, 周栋.腹腔镜胆囊切除术治疗急性胆囊炎[J].中国普通外科杂志, 2012, 21 (8) :1038-1040.
    [15]WANG WH.Clinical efficacy of percutaneous transhepatic cholecystostomy combined with laparoscopic cholecystectomy for elderly patients with severe calculous cholecystitis[J].J Clin Hepatol, 2015, 31 (8) :1291-1294. (in Chinese) 王为华.经皮经肝胆囊穿刺造瘘术联合腹腔镜下胆囊切除术治疗60岁以上重症结石性胆囊炎患者的疗效观察[J].临床肝胆病杂志, 2015, 31 (8) :1291-1294.
    [16]LIU C, ZHANG L.Clinical efficacy of transumbilical single-port laparoscopic cholecystectomy in treatment of acute cholecystitis[J].J Clin Hepatol, 2015, 31 (10) :1678-1681. (in Chinese) 刘超, 张磊.经脐单孔腹腔镜胆囊切除术治疗急性胆囊炎的效果评价[J].临床肝胆病杂志, 2015, 31 (10) :1678-1681.
    [17]KOMATSU S, TSUKAMOTO T, IWASAKI T, et al.Role of percutaneous transhepatic gallbladder aspiration in the early management of acute cholecystitis[J].J Dig Dis, 2014, 15 (12) :669-675.
    [18]CHOK KS, CHU FS, CHEUNG TT, et al.Results of percutaneous transhepatic cholecystostomy for high surgical risk patients with acute cholecystitis[J].ANZ J Surg, 2010, 80 (4) :280-283.
    [19]LIU H, FAN MM, CHANG YX, et al.Clincal analysis of cases converted to open surgery during laparoscopic cholecystectomy[J].Chin J Med Offic, 2016, 44 (8) :809-811. (in Chinese) 刘虎, 范明明, 常颜信, 等.腹腔镜胆囊切除术中转开腹临床分析[J].临床军医杂志, 2016, 44 (8) :809-811.
    [20]CHEN MJ, ZHENG JB.Sequential laparoscopic cholecystectomy compared with simple laparoscopic cholecystectomy in treating eld-erly acute severe cholecystitis[J].Anhui Med J, 2013, 34 (6) :756-758.陈敏捷, 郑剑波.经皮经肝胆囊穿刺序贯腹腔镜胆囊切除治疗老年急性重症胆囊炎效果比较[J].安徽医学, 2013, 34 (6) :756-758.
    [21]KWON YJ, AHN BK, PARK HK, et al.What is the optimal time for laparoscopic cholecystectomy in gallbladder empyema?[J].Surg Endosc, 2013, 27 (10) :3776-3780.
    [22]LO HC, WANG YC, SU LT, et al.Can early laparoscopic cholecystectomy be the optimal management of cholecystitis with gallbladder perforation?A single institute experience of 74 cases[J].Surg Endosc, 2012, 26 (11) :3301-3306.
    [23]YANG HQ, NIU JH, ZHANG SJ, et al.Laparoscopic cholecystectomy following percutaneous transhepatic gallbladder drainage for patients with severe acute cholecystitis[J].J Abdominal Surg, 2012, 25 (2) :100-101. (in Chinese) 杨宏强, 牛建华, 张示杰, 等.高危急性胆囊炎经PTGD处理后再行腹腔镜胆囊切除术137例[J].腹部外科, 2012, 25 (2) :100-101.
    [24]TAO P, WU XY, ZHANG L.Clinical effect of ultrasound-guided percutaneous transhepatic gallbladder drainage in treatment of acute cholecystitis in elderly patients[J].J Clin Hepatol, 2016, 32 (10) :1929-1931. (in Chinese) 陶平, 吴向阳, 张磊.超声引导经皮经肝胆囊穿刺引流术治疗老年急性胆囊炎的效果分析[J].临床肝胆病杂志, 2016, 32 (10) :1929-1931.
    [25]JIANG HS, HUANG B, GAN WB.Percutaneous transhepatic gallbladder drainage combined with laparoscopiccholecystectomy in severe acute cho-lecystitis for the elderly patients[J].Sichuan Med, 2015, 36 (7) :999-1001. (in Chinese) 江华山, 黄斌, 甘文斌.经皮经肝胆囊穿刺引流后择期性腹腔镜胆囊切除治疗老年急性重症胆囊炎的临床观察[J].四川医学, 2015, 36 (7) :999-1001.
    [26]QIU M.Timing of the laparoscopic cholecystectomy after PTGD for acute cholecystitis[D].Shihezi:Shihezi Univ, 2014. (in Chinese) 邱明.急性胆囊炎经皮经肝胆囊穿刺引流术后手术时机的选择[D].石河子:石河子大学, 2014.
    [27]JIANG QH, WANG AZ, CUI WH.The influence of operation effects of timing of the laparoscopic cholecystectomy after PTGD for acute cholecystitis[J].Modern Med J, 2015, 43 (7) :832-836. (in Chinese) 姜庆贺, 王爱芝, 崔文海.经肝胆囊穿刺置管引流术后不同手术时机对急性胆囊炎患者手术效果的影响[J].现代医学, 2015, 43 (7) :832-836.
  • Relative Articles

    [1]Chinese Association of Integrative Medicine, Chinese Association of Integrative Medicine, Chinese Medical Association. Guidelines for integrated traditional Chinese and Western medicine diagnosis and treatment of liver cirrhosis[J]. Journal of Clinical Hepatology, 2023, 39(11): 2543-2549. doi: 10.3969/j.issn.1001-5256.2023.11.005
    [2]Chinese Association of Integrative Medicine, China Association of Chinese Medicine, Chinese Medical Association. Guidelines for the integrated traditional Chinese and Western medicine diagnosis and treatment of acute-on-chronic liver failure[J]. Journal of Clinical Hepatology, 2023, 39(7): 1547-1552. doi: 10.3969/j.issn.1001-5256.2023.07.006
    [3]Shili JIANG, Ping LIU. Research advances in integrated traditional Chinese and Western medicine therapy for liver cirrhosis[J]. Journal of Clinical Hepatology, 2022, 38(9): 1953-1955. doi: 10.3969/j.issn.1001-5256.2022.09.001
    [4]Xianbo WANG, Ke SHI. Integrated traditional Chinese and Western medicine diagnosis and treatment of hepatic encephalopathy: Advances and perspectives[J]. Journal of Clinical Hepatology, 2022, 38(9): 1969-1973. doi: 10.3969/j.issn.1001-5256.2022.09.004
    [5]Changqing ZHAO. Integrated traditional Chinese and Western medicine diagnosis and treatment of liver cirrhosis with diabetes[J]. Journal of Clinical Hepatology, 2022, 38(9): 1980-1985. doi: 10.3969/j.issn.1001-5256.2022.09.006
    [6]Jiaqi LIANG, Wen LIU. Integrated traditional Chinese and Western medicine diagnosis and treatment of hepatorenal syndrome[J]. Journal of Clinical Hepatology, 2022, 38(9): 1974-1979. doi: 10.3969/j.issn.1001-5256.2022.09.005
    [7]Lei WANG. Integrated traditional Chinese and Western medicine diagnosis and treatment of cirrhotic ascites[J]. Journal of Clinical Hepatology, 2022, 38(9): 1956-1961. doi: 10.3969/j.issn.1001-5256.2022.09.002
    [8]Chinese Association of Integrative Medicine. Expert consensus on the diagnosis and treatment of acute-on-chronic liver failure with integrated traditional Chinese and Western medicine[J]. Journal of Clinical Hepatology, 2021, 37(9): 2045-2053. doi: 10.3969/j.issn.1001-5256.2021.09.009
    [9]Wang XiaoJing, Liu Yao, Wang XianBo. Biochemical response and integrated traditional Chinese and Western medicine therapy for primary biliary cholangitis[J]. Journal of Clinical Hepatology, 2020, 36(1): 26-30. doi: 10.3969/j.issn.1001-5256.2020.01.004
    [10]Jiang ShiLi, Liu Ping. Current status and perspectives of integrated traditional Chinese and Western medicine therapy for hepatobiliary and pancreatic diseases[J]. Journal of Clinical Hepatology, 2020, 36(1): 10-13. doi: 10.3969/j.issn.1001-5256.2020.01.001
    [11]Liver Disease Committee, Chinese Association of Integrative Medicine. Guidelines for the diagnosis and treatment of liver fibrosis in integrative medicine practice (2019)[J]. Journal of Clinical Hepatology, 2019, 35(7): 1444-1449. doi: 10.3969/j.issn.1001-5256.2019.07.007
    [12]Liu Ping. A clinical analysis of strengthening integrated traditional Chinese and Western medicine therapy for prevention and treatment of liver cancer[J]. Journal of Clinical Hepatology, 2016, 32(4): 615-618. doi: 10.3969/j.issn.1001-5256.2016.04.001
    [13]Li Jun. Clinical research progress in integrated traditional Chinese and Western medicine therapy for HBV-related liver failure[J]. Journal of Clinical Hepatology, 2015, 31(1): 42-47. doi: 10.3969/j.issn.1001-5256.2015.01.010
    [14]Wang XianBo, Sun Le. Progress and prospect of diagnosis and treatment of hepatic fibrosis by integrated traditional Chinese and Western medicine therapy[J]. Journal of Clinical Hepatology, 2015, 31(1): 38-41. doi: 10.3969/j.issn.1001-5256.2015.01.009
    [15]Wei BeiHai, Zhou Tao. Current and future perspectives on integrative traditional Chinese and Western medical management of gastroenterological diseases[J]. Journal of Clinical Hepatology, 2013, 29(4): 241-244.
    [16]Liu ChengHai, Xing Feng. The potential benefit managing ascites due to cirrhosis using an integrative medicine approach[J]. Journal of Clinical Hepatology, 2013, 29(4): 253-256.
    [17]Yao XiXian, Yao DongMei. Combination treatment of Chinese traditional and Western medicine in chronic hepatitis and liver fibrosis[J]. Journal of Clinical Hepatology, 2013, 29(4): 245-248+252.
    [18]Zhou ShuangNan, Wang LiFu, Yang HuiYin, Bai YunFeng, Li Yun. Analysis of clinical effects and prognosis of patients with early-mid stage chronic severe hepatitis B treated with integrated traditional and western medicine[J]. Journal of Clinical Hepatology, 2011, 27(5): 471-473.
    [19]Tang ZhaoYou. Combination of traditional Chinese medicine and western medicine in the treatment of liver cancer[J]. Journal of Clinical Hepatology, 2011, 27(5): 449-450.
    [20]Li YouTian, Li Yang, Li Bing. Effect of combination of traditional chinese medicine and western medicine on ascites resulted from liver cirrhosis[J]. Journal of Clinical Hepatology, 2003, 19(3): 150-151.
  • Cited by

    Periodical cited type(16)

    1. 巴明玉,潘研,王娴,陈亚琳,燕树勋. 强肝胶囊对非酒精性脂肪肝肥胖患者糖脂代谢水平及肝功能的影响. 中医学报. 2024(02): 416-420 .
    2. 范文,郑垂仰,周旋,孔怡琳,潘丰满,杨钦河,张玉佩. 6种中成药治疗非酒精性脂肪性肝病有效性和安全性的网状Meta分析. 中药新药与临床药理. 2023(11): 1612-1622 .
    3. 崔姗姗,刘英,江霞. 非酒精性脂肪性肝病与胰岛素抵抗的研究进展. 医学信息. 2022(10): 66-69 .
    4. 舒祥兵,操颖,顾晔,杨志新,季光,张莉. 强肝胶囊促进肝糖原合成降低大鼠高血糖的机制研究. 上海中医药大学学报. 2021(03): 45-51 .
    5. 贾英杰,张晓博,张新元,杨红霞,郭争荣. 强肝胶囊对猪血清诱导大鼠肝纤维化的治疗作用. 河北医药. 2021(20): 3104-3107 .
    6. 朱丹,孙婷婷,陈兰羽,谢铮. 脂肪性肝病中医药认识. 辽宁中医药大学学报. 2020(05): 70-73 .
    7. 崔翔,刘玲兰,华鹏,郭薇,薛敬东. 从脾论治非酒精性脂肪性肝病的体会与研究概况. 中医临床研究. 2020(14): 136-138 .
    8. 郭明升,刘娟,郭英杰,籍芳华,郝艳爽. 阿托伐他汀联用脂康颗粒或强肝胶囊用于脑梗死二级预防效果比较. 现代中西医结合杂志. 2020(22): 2400-2404+2446 .
    9. 王秀琴. 强肝胶囊联合甘草酸二铵肠溶胶囊治疗非酒精性脂肪肝的效果. 河南医学研究. 2019(06): 1089-1091 .
    10. 黄静,陈湘清,郭东升,吴奋. 同步抗感染治疗对合并幽门螺杆菌感染非酒精性脂肪肝病患者治疗结局的影响研究. 重庆医学. 2018(01): 97-100 .
    11. 陈少颖,易新宇,周小博,张荣臻. 中医药治疗非酒精性脂肪肝的研究进展. 大众科技. 2018(06): 68-70 .
    12. 周桃梅,杨上文,汪剑波. 强肝胶囊联合二甲双胍治疗非酒精性脂肪肝的疗效及其对Nod样受体-3炎症小体的影响. 中国医院统计. 2018(03): 206-208 .
    13. 柳琳琳,毛德文,吕建林,黄瑞. 强肝胶囊对非酒精性脂肪性肝病患者疗效及安全性的Meta分析. 中成药. 2018(08): 1715-1720 .
    14. 李滨,张佳圆,王凤永,李春晖,齐丽韫,王玉华,赵培利. 胆宁片治疗非酒精性脂肪肝临床效果及对血脂、肝功能和肝纤维化的影响. 解放军医药杂志. 2018(10): 93-96 .
    15. 朱紫馨,祝丽丽,程明亮. 同步抗感染治疗非酒精性脂肪肝合并幽门螺杆菌感染的效果观察. 临床合理用药杂志. 2018(31): 58-59 .
    16. 李军祥,王允亮,郭一,谢添弘. 中医药治疗非酒精性脂肪性肝病专题笔谈. 中国中西医结合消化杂志. 2017(11): 801-804 .

    Other cited types(13)

  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (2381) PDF downloads(450) Cited by(29)
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return